|
1
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Daaboul HE, Daher CF, Bodman-Smith K,
Taleb RI, Shebaby WN, Boulos J, Dagher C, Mroueh MA and El-Sibai M:
Antitumor activity of β-2-himachalen-6-ol in colon cancer is
mediated through its inhibition of the PI3K and MAPK pathways. Chem
Biol Interact. 275:162–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cragg GM and Newman DJ: Plants as a source
of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen R, Xue J and Xie M: Puerarin prevents
isoprenaline-induced myocardial fibrosis in mice by reduction of
myocardial TGF-β1 expression. J Nutr Biochem. 23:1080–1085. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou YX, Zhang H and Peng C: Puerarin: A
review of pharmacological effects. Phytother Res. 28:961–975. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Q, Wu T, Chen X, Ni J, Duan X, Zheng
J, Qiao J, Zhou L and Wei J: Puerarin injection for unstable angina
pectoris. Cochrane Database Syst Rev. 19:CD0041962006.
|
|
9
|
Song W, Li YJ, Qiao X, Qian Y and Ye M:
Chemistry of the Chinese herbal medicine Puerariae Radix (Ge-Gen):
A review. J Chin Pharm Sci. 23:347–360. 2014. View Article : Google Scholar
|
|
10
|
Chen T, Chen H, Wang Y and Zhang J: In
vitro and in vivo antitumour activities of puerarin 6“-O-xyloside
on human lung carcinoma A549 cell line via the induction of the
mitochondria-mediated apoptosis pathway. Pharm Biol. 54:1793–1799.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fokunang CN, Ndikum V, Tabi OY, Jiofack
RB, Ngameni B, Guedje NM, Tembe-Fokunang EA, Tomkins P, Barkwan S,
Kechia Fz, et al: Traditional medicine: Past, present and future
research and development prospects and integration in the national
health system of Cameroon. Afr J Tradit Complement Altern Med.
8:284–295. 2011.PubMed/NCBI
|
|
12
|
Xie Q, Yang Y, Wang Z, Chen F, Zhang A and
Liu C: Resveratrol-4-O-D-(2′-galloyl)-glucopyranoside isolated from
Polygonum cuspidatum exhibits anti-hepatocellular carcinoma
viability by inducing apoptosis via the JNK and ERK pathway.
Molecules. 19:1592–1602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mattern J and Volm M: Imbalance of cell
proliferation and apoptosis during progression of lung carcinomas.
Anticancer Res. 24:4243–4246. 2004.PubMed/NCBI
|
|
14
|
Liu YL, Tang LH, Liang ZQ, You BG and Yang
SL: Growth inhibitory and apoptosis inducing by effects of total
flavonoids from Lysimachia clethroides Du by in human chronic
myeloid leukemia K562 cells. J Ethnopharmacol. 131:1–9. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kroemer G, Galluzzi L, Vandenabeele P,
Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS,
Golstein P, Green DR, et al: Classification of cell death:
Recommendations of the nomenclature committee on cell death. Cell
Death Differ. 16:3–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okada H and Mak TW: Pathways of apoptotic
and non-apoptotic death in tumor cells. Nat Rev Cancer. 4:592–603.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu P, Shi L, Song M and Meng Y: Antitumor
activity of paederosidic acid in human non-small cell lung cancer
cells via inducing mitochondria-mediated apoptosis. Chem Biol
Interact. 269:33–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Jiang S, Li Y, Li M, Cheng Q, Zhao
D, Yang B, Jia Z, Wang L and Song L: Caspase-3 serves as an
intracellular immune receptor specific for lipopolysaccharide in
oyster Crassostrea gigas. Dev Comp Immunol. 61:1–12. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao N, Budhraja A, Cheng S, Yao H, Zhang Z
and Shi X: Induction of apoptosis in human leukemia cells by grape
seed extract occurs via activation of c-Jun NH2-terminal kinase.
Clin Cancer Res. 15:140–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang XK, Xu MY, Xu GS, Zhang YL and Xu ZX:
In vitro and in vivo antitumor activity of scutebarbatine A on
human lung carcinoma A549 cell lines. Molecules. 19:8740–8751.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng W, Wu JG, Jiang YB, Liu YJ, Sun T, Wu
N and Wu CJ: Antitumor activity of
4-O-(2ˮ-O-acetyl-6ˮ-O-p-coumaroyl-β-D-glucopyranosyl)-p-coumaric
acid against lung cancers via mitochondrial-mediated apoptosis.
Chem Biol Interact. 233:8–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chipuk JE, McStay GP, Bharti A, Kuwana T,
Clarke CJ, Siskind LJ, Obeid LM and Green DR: Sphingolipid
metabolism cooperates with BAK and BAX to promote the mitochondrial
pathway of apoptosis. Cell. 148:988–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Budhraja A, Gao N, Zhang Z, Son YO, Cheng
S, Wang X, Ding S, Hitron A, Chen G, Luo J and Shi X: Apigenin
induces apoptosis in human leukemia cells and exhibits
anti-leukemic activity in vivo. Mol Cancer Ther. 11:132–142. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 48:6245–6251. 2008. View Article : Google Scholar
|
|
25
|
Wang K, Zhang C, Bao J, Jia X, Liang Y,
Wang X, Chen M, Su H, Li P, Wan JB and He C: Synergistic
chemopreventive effects of curcumin and berberine on human breast
cancer cells through induction of apoptosis and autophagic cell
death. Sci Rep. 6:260642016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang Y, Goldberg ID and Shi YE: Complex
roles of tissue inhibitors of metalloproteinases in cancer.
Oncogene. 21:2245–2252. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vihinen P, Ala-aho R and Kähäri VM: Matrix
metalloproteinases as therapeutic targets in cancer. Curr Cancer
Drug Targets. 5:203–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo HZ, Huang ZH, Yu YL, Chen H, Zhou SH
and Deng QY: Expression of MMP-9 in colon cancer and its clinical
significance. J Oncol. 15:552–553. 2009.
|
|
29
|
Traub S, Morgner J, Martino MM, Höning S,
Swartz MA, Wickström SA, Hubbell JA and Eming SA: The promotion of
endothelial cell attachment and spreading using FNIII10 fused to
VEGF-A165. Biomaterials. 34:5958–5968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang ZG and Zhu HG: Vascular endothelial
growth factor (VEGF) and pancreatic cancer. J Dig Surg. 4:149–151.
2005.
|
